Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Keryx Biopharma gets U.S. approval for kidney drug
Yahoo/Reuters
Friday, September 5, 2014 - 11:58am
tags:
FDA, Keryx, Zerenex, chronic kidney disease
Asthma: It’s a mAb, mAb, mAb, mAb world says analyst
Bio-Pharma Reporter
Friday, September 5, 2014 - 11:20am
tags:
asthma, monoclonal antibodies, Sanofi, Regeneron, Roche, GSK, AstraZeneca
Lilly Backs Lawsuit Against CMS Over its Alzheimer’s Diagnostic Drug
WSJ Pharmalot
Friday, September 5, 2014 - 11:10am
tags:
Eli Lilly, Alzheimer's disease, Amyvid, CMS, Medicare, Medicaid
FDA Draft Guidance Could Spur Innovation in Diabetes, Cardio Spaces
Medical Device and Diagnostics Industry
Friday, September 5, 2014 - 10:32am
tags:
FDA, innovation, diabetes, cardiology, devices
Drug black box warnings up post-Vioxx withdrawal
Oncology Practice
Friday, September 5, 2014 - 10:29am
tags:
black box, warnings
In FDA Effort to Strengthen Regulation of Compounded Drugs, Protections and Profits Intersect
RAPS.org
Friday, September 5, 2014 - 10:27am
tags:
FDA, compounding pharmacies
Recro tanks after hitting the brakes on its lead pain drug
Fierce Biotech
Friday, September 5, 2014 - 10:22am
tags:
Recro Pharma, Dex-IN, painkillers
OncoMed gets back on track as FDA clears another clinical hold
Fierce Biotech
Friday, September 5, 2014 - 10:21am
tags:
OncoMed, FDA, FZD8-Fc, ipafricept
A New Class of Cardiovascular Drug
The Chairman's Blog
Friday, September 5, 2014 - 10:13am
tags:
Capstone Therapeutics, AEM-28, Homozygous Familial Hypercholesterolemia
Cancer Drug Approval Is A Triumph For Merck. What's Next?
Forbes
Friday, September 5, 2014 - 10:04am
tags:
Merck, melanoma, Keytruda, Bristol-Myers Squibb, Opdivo
Smartphones and social media to gather drug safety data
Pharmaphorum
Friday, September 5, 2014 - 8:43am
tags:
social media, drug safety
Cheaper Version Of Gilead's Sovaldi Might Be On The Cards
Bidness Etc.
Friday, September 5, 2014 - 8:05am
tags:
Gilead Sciences, Sovaldi, hepatitis C
Mallinckrodt's Pain Drug Shows Efficacy in Phase 3
Drug Discovery and Development
Friday, September 5, 2014 - 8:04am
tags:
Mallinckrodt, painkillers, MNK-155
Alkermes Completes Enrolment for Phase II ALKS 3831 Study
Yahoo/Zacks.com
Friday, September 5, 2014 - 7:57am
tags:
Alkermes, ALKS 3831, schizophrenia
Abbott Labs' Weakness in Devices Hurts Long-Term Growth Potential
TheStreet.com
Friday, September 5, 2014 - 7:54am
tags:
Abbott Labs, devices
Blockbusters Differentiate Novartis
Morningstar
Friday, September 5, 2014 - 7:53am
tags:
Novartis, LCZ696
J&J Aware of Hip Poisoning Worry in 2001, Lawyer Says
Bloomberg
Friday, September 5, 2014 - 7:47am
tags:
hip implants, JNJ, DePuy, Pinnacle Hip
Gilead Close to Sending $84,000 Drug to Poor Countries
Bloomberg
Thursday, September 4, 2014 - 6:30pm
tags:
Gilead Sciences, Sovaldi, hepatitis C
FDA OKs Merck melanoma drug, 1st in new class of cancer drugs with big advantages over chemo
Yahoo/AP
Thursday, September 4, 2014 - 6:11pm
tags:
Merck, FDA, melanoma, Keytruda
AstraZeneca Called the White House to say: Stop Those Tax Inversions!!
WSJ Pharmalot
Thursday, September 4, 2014 - 11:35am
tags:
AstraZeneca, tax inversions, Pfizer, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.